![]() C2N Diagnostics C2N Diagnostics is a company that develops and commercializes diagnostics for Alzheimer’s disease and related forms of neurodegeneration. | ![]() Alector Alector is a biotechnology company that develops therapies for the treatment of neurodegenerative diseases. | ![]() Crossbeta Biosciences Crossbeta Biosciences is a biotech company, which develops a technology to generate stable oligomers for drug discovery and development in various disease areas. | ![]() Alseres Pharmaceuticals Alseres Pharmaceuticals, Inc. (ALSE) is focused on the development of diagnostic and therapeutic products for disorders in the central nervous system (CNS). | |
Founding Date | Founding Date 2007 | Founding Date 2013 | Founding Date 2005 | Founding Date 1972 |
Type | Type Private | Type Public | Type Private | Type Private |
Tags | ||||
Locations | Locations St. Louis, US HQ | Locations San Francisco, US HQ | Locations Utrecht, NL HQ Utrecht, NL | Locations Newton, US HQ |
Employees | Employees 96 | Employees 2382% decrease | Employees 2 | Employees 4 |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $21m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $473.7k (FY, 2013) |
Net income | Net income N/A | Net income ($142.9m) (FY, 2025) | Net income N/A | Net income ($941.5k) (FY, 2013) |
Funding | ||||
Total funding raised | Total funding raised $ 20m | Total funding raised $ 194.5m | Total funding raised N/A | Total funding raised N/A |

Alector is a biotechnology company that develops therapies for the treatment of neurodegenerative diseases.
View company
Crossbeta Biosciences is a biotech company, which develops a technology to generate stable oligomers for drug discovery and development in various disease areas.
View company
Alseres Pharmaceuticals, Inc. (ALSE) is focused on the development of diagnostic and therapeutic products for disorders in the central nervous system (CNS).
View company